Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany
Abstract To investigate the associations of leptin, adiponectin and high-sensitive (hs) C-reactive protein (CRP) with risk and prognosis of amyotrophic lateral sclerosis (ALS). Data from a population-based case-control study in Southern Germany (10/2010–6/2014) of 289 ALS patients (mean age of 65.7...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8d66d0c8914b4668a9930c9e57470215 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8d66d0c8914b4668a9930c9e57470215 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8d66d0c8914b4668a9930c9e574702152021-12-02T11:40:52ZAdipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany10.1038/s41598-017-04706-52045-2322https://doaj.org/article/8d66d0c8914b4668a9930c9e574702152017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04706-5https://doaj.org/toc/2045-2322Abstract To investigate the associations of leptin, adiponectin and high-sensitive (hs) C-reactive protein (CRP) with risk and prognosis of amyotrophic lateral sclerosis (ALS). Data from a population-based case-control study in Southern Germany (10/2010–6/2014) of 289 ALS patients (mean age of 65.7 (SD 10.5) years, 59.5% men) and 506 controls were included. During median follow-up of 14.5 months of 279 ALS patients 104 (53.9% men, 68.9 (10.3) years) died. Serum samples were measured for leptin, adiponectin and hs-CRP. Conditional logistic regression was used to estimate ALS risk. Survival models were used to appraise the prognostic value. ALS patients were characterized by lower levels of school education, BMI and smoking prevalence. Adjusted for covariates, leptin was inversely associated with ALS risk (top vs. bottom quartile: OR 0.49; 95% CI 0.29–0.80), while for adiponectin a positive association was found (OR 2.89; 95% CI 1.78–4.68). Among ALS patients increasing leptin concentrations were associated with longer survival (p for trend 0.002), while for adiponectin no association was found (p for trend 0.55). For hs-CRP no association was found. Leptin and adiponectin, two key hormones regulating energy metabolism, were strongly and independently related with ALS risk. Leptin levels were further negatively related with overall survival of ALS patients.Gabriele NagelRaphael S. PeterAngela RosenbohmWolfgang KoenigLuc DupuisDietrich RothenbacherAlbert C. LudolphNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Gabriele Nagel Raphael S. Peter Angela Rosenbohm Wolfgang Koenig Luc Dupuis Dietrich Rothenbacher Albert C. Ludolph Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany |
description |
Abstract To investigate the associations of leptin, adiponectin and high-sensitive (hs) C-reactive protein (CRP) with risk and prognosis of amyotrophic lateral sclerosis (ALS). Data from a population-based case-control study in Southern Germany (10/2010–6/2014) of 289 ALS patients (mean age of 65.7 (SD 10.5) years, 59.5% men) and 506 controls were included. During median follow-up of 14.5 months of 279 ALS patients 104 (53.9% men, 68.9 (10.3) years) died. Serum samples were measured for leptin, adiponectin and hs-CRP. Conditional logistic regression was used to estimate ALS risk. Survival models were used to appraise the prognostic value. ALS patients were characterized by lower levels of school education, BMI and smoking prevalence. Adjusted for covariates, leptin was inversely associated with ALS risk (top vs. bottom quartile: OR 0.49; 95% CI 0.29–0.80), while for adiponectin a positive association was found (OR 2.89; 95% CI 1.78–4.68). Among ALS patients increasing leptin concentrations were associated with longer survival (p for trend 0.002), while for adiponectin no association was found (p for trend 0.55). For hs-CRP no association was found. Leptin and adiponectin, two key hormones regulating energy metabolism, were strongly and independently related with ALS risk. Leptin levels were further negatively related with overall survival of ALS patients. |
format |
article |
author |
Gabriele Nagel Raphael S. Peter Angela Rosenbohm Wolfgang Koenig Luc Dupuis Dietrich Rothenbacher Albert C. Ludolph |
author_facet |
Gabriele Nagel Raphael S. Peter Angela Rosenbohm Wolfgang Koenig Luc Dupuis Dietrich Rothenbacher Albert C. Ludolph |
author_sort |
Gabriele Nagel |
title |
Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany |
title_short |
Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany |
title_full |
Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany |
title_fullStr |
Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany |
title_full_unstemmed |
Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany |
title_sort |
adipokines, c-reactive protein and amyotrophic lateral sclerosis – results from a population- based als registry in germany |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/8d66d0c8914b4668a9930c9e57470215 |
work_keys_str_mv |
AT gabrielenagel adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany AT raphaelspeter adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany AT angelarosenbohm adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany AT wolfgangkoenig adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany AT lucdupuis adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany AT dietrichrothenbacher adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany AT albertcludolph adipokinescreactiveproteinandamyotrophiclateralsclerosisresultsfromapopulationbasedalsregistryingermany |
_version_ |
1718395528895528960 |